Sort   by:  
 Page size 
UnknownThe impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study.
Not available
S-EPMC7524572 | biostudies-literature
UnknownAcceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries.
Not available
S-EPMC8668191 | biostudies-literature
UnknownCOVID-19 severity, breakthrough infections and vaccine safety in young individuals with autoimmune diseases: insights from the COVAD study.
Not available
S-EPMC11343807 | biostudies-literature
UnknownCOVAD survey 2 long-term outcomes: unmet need and protocol.
Not available
S-EPMC9376047 | biostudies-literature
UnknownLong-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study.
Not available
S-EPMC10348925 | biostudies-literature
UnknownCOVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group.
Not available
S-EPMC10766674 | biostudies-literature
UnknownThe impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD dataset.
Not available
S-EPMC11962953 | biostudies-literature
UnknownCorrection to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies.
Not available
S-EPMC11618184 | biostudies-literature
UnknownDisease burden in inflammatory arthritis: an unsupervised machine learning approach of the COVAD-2 e-survey dataset.
Not available
S-EPMC12007600 | biostudies-literature
UnknownComment on: Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey: Reply.
Not available
S-EPMC11374017 | biostudies-literature
Sort   by:  
 Page size